<DOC>
	<DOCNO>NCT00695435</DOCNO>
	<brief_summary>To evaluate Tobramycin tear concentration value TOBRADEX® Ophthalmic Suspension , Tobramycin 0.3 % / Dexamethasone 0.05 % Ophthalmic Suspension versus TOBREX® Ophthalmic Solution normal volunteer .</brief_summary>
	<brief_title>Tobramycin Tear Concentrations</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Inclusion : Visual Acuity ( VA ) 0.6 logMAR good Tear meniscus height ≥ 0.3mm Visit 1 . No concomitant topical ocular medication , include artificial tear , study period Exclusion ocular hypertension , iritis uveitis , glaucoma ocular surgery , intraocular surgery ocular laser procedure either eye within past six month epithelial herpes simplex ( dendritic keratitis ) ; Vaccinia , active recent varicella viral disease cornea and/or conjunctiva ; ocular Rosacea ; Mycobacterial infection eye ; / fungal disease eye lacrimal duct obstruction , dry eye , ocular allergy . contact lens within 7 day Visit 1. ocular medication within 14 day Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>normal volunteer</keyword>
	<keyword>anti-infective</keyword>
	<keyword>tobramycin</keyword>
</DOC>